An emergency medical services team brings a 71-year-old male to the resuscitation bay following 48 hours of progressively worsening shortness of breath, rapid heart rate, and increased production of thick, yellowish sputum. He has a documented medical history of chronic obstructive pulmonary disease (COPD), essential hypertension, and major depressive disorder. Current home pharmacological therapies consist of amlodipine, a combined fluticasone-salmeterol inhaler, and citalopram.
Initial vital signs obtained upon arrival demonstrate a temperature of (), blood pressure of , heart rate of , and respiratory rate of . Pulse oximetry indicates an oxygen saturation of while breathing ambient air.
Physical assessment highlights a barrel-shaped chest with prominent utilization of accessory muscles of respiration. Thoracic auscultation reveals global expiratory wheezing intermixed with coarse rhonchi. Evaluation of the cardiovascular system demonstrates a tachycardic, irregularly irregular rhythm featuring variable intensity of the first heart sound (S1); no S3 gallop or murmurs are appreciated. The jugular venous pressure is measured at . Trace bilateral lower extremity edema is noted.
A 12-lead electrocardiogram (ECG) reveals an irregularly irregular rhythm with narrow QRS complexes. Closer inspection of lead II identifies varying PR intervals and at least three distinct P-wave morphologies preceding the QRS complexes. The calculated QTc interval is .
Arterial blood gas parameters on room air are as follows:
| Parameter | Value |
|---|---|
| pH | |
Which of the following interventions represents the most appropriate initial management step for this patient's specific cardiac rhythm abnormality?
- Delivery of systemic corticosteroids, short-acting bronchodilators, and targeted supplemental oxygenAnswer
- BInitiation of an intravenous loop diuretic bolus
- CAdministration of an intravenous amiodarone infusion
- DAdministration of an intravenous sodium bicarbonate infusion
- EInitiation of empiric intravenous vancomycin and piperacillin-tazobactam